Homology Medicines, Inc.’s $165 Million Initial Public Offering

Shearman & Sterling advised the underwriters of Homology Medicines, Inc.’s initial public offering of 10,350,000 shares of common stock (including 1,350,000 shares purchased by the underwriters…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now